BAKER BROS ADVISORS LLC Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for BAKER BROS ADVISORS LLC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of BAKER BROS ADVISORS LLC. BAKER BROS ADVISORS LLC is 10% Owner in BIOCRYST PHARMACEUTICALS INC ($BCRX) and Director in INCYTE CORP ($INCY) and Director in ALEXION PHARMACEUTICALS INC ($ALXN) and 10% Owner in IDERA PHARMACEUTICALS, INC. ($IDRA) and Director in IDERA PHARMACEUTICALS, INC. ($IDRA) and in XOMA Corp ($XOMA) and Director in ACADIA PHARMACEUTICALS INC ($ACAD) and Director in SEATTLE GENETICS INC /WA ($SGEN) and Director in GENOMIC HEALTH INC ($GHDX) and 10% Owner in BELLICUM PHARMACEUTICALS, INC ($BLCM) and 10% Owner in AQUINOX PHARMACEUTICALS, INC ($AQXP) and Director in AQUINOX PHARMACEUTICALS, INC ($AQXP) and Director in Zymeworks Inc. ($ZYME) and Director in Kodiak Sciences Inc. ($KOD) and 10% Owner in Invitae Corp ($NVTA) and Director in IGM Biosciences, Inc. ($IGMS) and 10% Owner in Atreca, Inc. ($BCEL) and in Mirati Therapeutics, Inc. ($MYG) and 10% Owner in Mirati Therapeutics, Inc. ($MYG) and Director in Talis Biomedical Corp ($TLIS) and Director in Aeglea BioTherapeutics, Inc. ($AGLE) and in RHYTHM PHARMACEUTICALS, INC. ($RYTM) and in Intellia Therapeutics, Inc. ($NTLA) and Director in BeiGene, Ltd. ($BGNE) and Director in Prelude Therapeutics Inc ($PRLD) and Director in Kiniksa Pharmaceuticals, Ltd. ($KNSA) and in HOOKIPA Pharma Inc. ($HOOK).
Latest Insider Trading Transactions of BAKER BROS ADVISORS LLC
Sentiment: All, ACAD, AGLE, ALXN, BCEL, BGNE, BLCM, BCRX, GHDX, HOOK, IDRA, IGMS, INCY, NTLA, NVTA, KNSA, KOD, MYG, NLTX, PRLD, RYTM, SGEN, TLIS, XOMA, ZYME
Page: < prev 1 2 3 4 5 6 7 8 ... 11 next >
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 30 2019 | ALXN | ALEXION PHARMACEUT ... | BAKER BROS. ADVISORS LP | Director | Sell | S | 126.25 | 1,867 | 235,713 | 983,179 | 985 K to 983.2 K (-0.19 %) |
| May 22 2019 | SGEN | SEATTLE GENETICS I ... | BAKER BROS. ADVISORS LP | Director | Option Exercise | A | 64.38 | 7,038 | 453,106 | 7,038 | |
| May 22 2019 | SGEN | SEATTLE GENETICS I ... | BAKER BROS. ADVISORS LP | Director | Option Exercise | A | 64.38 | 7,038 | 453,106 | 7,038 | |
| May 22 2019 | SGEN | SEATTLE GENETICS I ... | BAKER BROS. ADVISORS LP | Director | Grant | A | 0.00 | 2,963 | 0 | 45,842,649 | 45.8 M to 45.8 M (+0.01 %) |
| May 22 2019 | SGEN | SEATTLE GENETICS I ... | BAKER BROS. ADVISORS LP | Director | Grant | A | 0.00 | 2,963 | 0 | 5,304,837 | 5.3 M to 5.3 M (+0.06 %) |
| May 01 2019 | SGEN | SEATTLE GENETICS I ... | BAKER BROS. ADVISORS LP | Director | Option Exercise | M | 8.38 | 10,000 | 83,800 | 0 | |
| May 01 2019 | SGEN | SEATTLE GENETICS I ... | BAKER BROS. ADVISORS LP | Director | Option Exercise | M | 8.38 | 10,000 | 83,800 | 0 | |
| May 01 2019 | SGEN | SEATTLE GENETICS I ... | BAKER BROS. ADVISORS LP | Director | Buy | M | 8.38 | 10,000 | 83,800 | 45,839,686 | 45.8 M to 45.8 M (+0.02 %) |
| May 01 2019 | SGEN | SEATTLE GENETICS I ... | BAKER BROS. ADVISORS LP | Director | Buy | M | 8.38 | 10,000 | 83,800 | 5,301,874 | 5.3 M to 5.3 M (+0.19 %) |
| Apr 30 2019 | INCY | INCYTE CORP | BAKER BROS. ADVISORS LP | Director | Option Exercise | A | 75.03 | 12,472 | 935,774 | 12,472 | |
| Apr 30 2019 | INCY | INCYTE CORP | BAKER BROS. ADVISORS LP | Director | Option Exercise | A | 75.03 | 12,472 | 935,774 | 12,472 | |
| Apr 30 2019 | INCY | INCYTE CORP | BAKER BROS. ADVISORS LP | Director | Option Exercise | A | 75.03 | 12,472 | 935,774 | 12,472 | |
| Apr 30 2019 | INCY | INCYTE CORP | BAKER BROS. ADVISORS LP | Director | Grant | A | 0.00 | 1,520 | 0 | 812,602 | 811.1 K to 812.6 K (+0.19 %) |
| Apr 30 2019 | INCY | INCYTE CORP | BAKER BROS. ADVISORS LP | Director | Grant | A | 0.00 | 1,520 | 0 | 29,290,533 | 29.3 M to 29.3 M (+0.01 %) |
| Apr 30 2019 | INCY | INCYTE CORP | BAKER BROS. ADVISORS LP | Director | Grant | A | 0.00 | 1,520 | 0 | 4,430,004 | 4.4 M to 4.4 M (+0.03 %) |
| Apr 23 2019 | HOOK | HOOKIPA Pharma Inc ... | BAKER BROS. ADVISORS LP | Option Exercise | C | 0.00 | 529,758 | 0 | 529,758 | ||
| Apr 23 2019 | HOOK | HOOKIPA Pharma Inc ... | BAKER BROS. ADVISORS LP | Option Exercise | C | 0.00 | 529,758 | 0 | 0 | ||
| Apr 23 2019 | HOOK | HOOKIPA Pharma Inc ... | BAKER BROS. ADVISORS LP | Option Exercise | C | 0.00 | 60,194 | 0 | 60,194 | ||
| Apr 23 2019 | HOOK | HOOKIPA Pharma Inc ... | BAKER BROS. ADVISORS LP | Option Exercise | C | 0.00 | 60,194 | 0 | 0 | ||
| Apr 23 2019 | HOOK | HOOKIPA Pharma Inc ... | BAKER BROS. ADVISORS LP | Option Exercise | C | 0.00 | 2,905,359 | 0 | 2,905,359 | ||
| Apr 23 2019 | HOOK | HOOKIPA Pharma Inc ... | BAKER BROS. ADVISORS LP | Option Exercise | C | 0.00 | 2,905,359 | 0 | 0 | ||
| Apr 23 2019 | HOOK | HOOKIPA Pharma Inc ... | BAKER BROS. ADVISORS LP | Option Exercise | C | 0.00 | 324,421 | 0 | 324,421 | ||
| Apr 23 2019 | HOOK | HOOKIPA Pharma Inc ... | BAKER BROS. ADVISORS LP | Option Exercise | C | 0.00 | 324,421 | 0 | 0 | ||
| Apr 23 2019 | HOOK | HOOKIPA Pharma Inc ... | BAKER BROS. ADVISORS LP | Buy | P | 14.00 | 820,729 | 11,490,206 | 820,729 | 0 to 820.7 K | |
| Apr 23 2019 | HOOK | HOOKIPA Pharma Inc ... | BAKER BROS. ADVISORS LP | Buy | P | 14.00 | 72,128 | 1,009,792 | 72,128 | 0 to 72.1 K | |
| Apr 12 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 65.32 | 9,232 | 603,070 | 7,639,338 | 7.6 M to 7.6 M (-0.12 %) |
| Apr 12 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 65.32 | 1,417 | 92,564 | 1,214,575 | 1.2 M to 1.2 M (-0.12 %) |
| Apr 12 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 65.32 | 244 | 15,939 | 241,891 | 242.1 K to 241.9 K (-0.10 %) |
| Apr 12 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 65.32 | 142 | 9,276 | 157,519 | 157.7 K to 157.5 K (-0.09 %) |
| Apr 12 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 65.32 | 11 | 719 | 49,893 | 49.9 K to 49.9 K (-0.02 %) |
| Apr 12 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 65.32 | 158 | 10,321 | 171,091 | 171.2 K to 171.1 K (-0.09 %) |
| Apr 12 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 67.13 | 63,775 | 4,281,177 | 7,648,570 | 7.7 M to 7.6 M (-0.83 %) |
| Apr 12 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 67.13 | 9,791 | 657,264 | 1,215,992 | 1.2 M to 1.2 M (-0.80 %) |
| Apr 12 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 67.13 | 1,688 | 113,314 | 242,135 | 243.8 K to 242.1 K (-0.69 %) |
| Apr 12 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 67.13 | 979 | 65,720 | 157,661 | 158.6 K to 157.7 K (-0.62 %) |
| Apr 12 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 67.13 | 74 | 4,968 | 49,904 | 50 K to 49.9 K (-0.15 %) |
| Apr 12 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 67.13 | 1,093 | 73,372 | 171,249 | 172.3 K to 171.2 K (-0.63 %) |
| Apr 12 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 64.62 | 173,085 | 11,184,701 | 7,712,345 | 7.9 M to 7.7 M (-2.19 %) |
| Apr 12 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 64.62 | 26,575 | 1,717,269 | 1,225,783 | 1.3 M to 1.2 M (-2.12 %) |
| Apr 12 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 64.62 | 4,581 | 296,023 | 243,823 | 248.4 K to 243.8 K (-1.84 %) |
| Apr 12 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 64.62 | 2,656 | 171,630 | 158,640 | 161.3 K to 158.6 K (-1.65 %) |
| Apr 12 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 64.62 | 202 | 13,053 | 49,978 | 50.2 K to 50 K (-0.40 %) |
| Apr 12 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 64.62 | 2,966 | 191,662 | 172,342 | 175.3 K to 172.3 K (-1.69 %) |
| Apr 12 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 66.61 | 106,054 | 7,063,981 | 7,885,430 | 8 M to 7.9 M (-1.33 %) |
| Apr 12 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 66.61 | 16,282 | 1,084,502 | 1,252,358 | 1.3 M to 1.3 M (-1.28 %) |
| Apr 12 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 66.61 | 2,807 | 186,967 | 248,404 | 251.2 K to 248.4 K (-1.12 %) |
| Apr 12 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 66.61 | 1,628 | 108,437 | 161,296 | 162.9 K to 161.3 K (-1.00 %) |
| Apr 12 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 66.61 | 124 | 8,259 | 50,180 | 50.3 K to 50.2 K (-0.25 %) |
| Apr 12 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 66.61 | 1,817 | 121,026 | 175,308 | 177.1 K to 175.3 K (-1.03 %) |
| Apr 12 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 67.42 | 60,618 | 4,086,914 | 7,991,484 | 8.1 M to 8 M (-0.75 %) |
| Apr 12 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 67.42 | 9,307 | 627,485 | 1,268,640 | 1.3 M to 1.3 M (-0.73 %) |
| Apr 12 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 67.42 | 1,604 | 108,143 | 251,211 | 252.8 K to 251.2 K (-0.63 %) |
| Apr 12 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 67.42 | 930 | 62,701 | 162,924 | 163.9 K to 162.9 K (-0.57 %) |
| Apr 12 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 67.42 | 71 | 4,787 | 50,304 | 50.4 K to 50.3 K (-0.14 %) |
| Apr 12 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 67.42 | 1,039 | 70,050 | 177,125 | 178.2 K to 177.1 K (-0.58 %) |
| Apr 10 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 69.12 | 10,832 | 748,735 | 8,052,102 | 8.1 M to 8.1 M (-0.13 %) |
| Apr 10 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 69.12 | 1,663 | 114,951 | 1,277,947 | 1.3 M to 1.3 M (-0.13 %) |
| Apr 10 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 69.12 | 287 | 19,838 | 252,815 | 253.1 K to 252.8 K (-0.11 %) |
| Apr 10 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 69.12 | 166 | 11,474 | 163,854 | 164 K to 163.9 K (-0.10 %) |
| Apr 10 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 69.12 | 13 | 899 | 50,375 | 50.4 K to 50.4 K (-0.03 %) |
| Apr 10 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 69.12 | 185 | 12,788 | 178,164 | 178.3 K to 178.2 K (-0.10 %) |
| Apr 10 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 68.70 | 102,618 | 7,049,918 | 8,062,934 | 8.2 M to 8.1 M (-1.26 %) |
| Apr 10 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 68.70 | 15,755 | 1,082,378 | 1,279,610 | 1.3 M to 1.3 M (-1.22 %) |
| Apr 10 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 68.70 | 2,716 | 186,591 | 253,102 | 255.8 K to 253.1 K (-1.06 %) |
| Apr 10 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 68.70 | 1,575 | 108,203 | 164,020 | 165.6 K to 164 K (-0.95 %) |
| Apr 10 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 68.70 | 120 | 8,244 | 50,388 | 50.5 K to 50.4 K (-0.24 %) |
| Apr 10 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 68.70 | 1,758 | 120,776 | 178,349 | 180.1 K to 178.3 K (-0.98 %) |
| Apr 10 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 67.68 | 15,543 | 1,051,888 | 8,165,552 | 8.2 M to 8.2 M (-0.19 %) |
| Apr 10 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 67.68 | 2,386 | 161,475 | 1,295,365 | 1.3 M to 1.3 M (-0.18 %) |
| Apr 10 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 67.68 | 411 | 27,815 | 255,818 | 256.2 K to 255.8 K (-0.16 %) |
| Apr 10 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 67.68 | 239 | 16,175 | 165,595 | 165.8 K to 165.6 K (-0.14 %) |
| Apr 10 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 67.68 | 18 | 1,218 | 50,508 | 50.5 K to 50.5 K (-0.04 %) |
| Apr 10 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 67.68 | 266 | 18,002 | 180,107 | 180.4 K to 180.1 K (-0.15 %) |
| Apr 10 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 67.87 | 1,813 | 123,047 | 8,181,095 | 8.2 M to 8.2 M (-0.02 %) |
| Apr 10 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 67.87 | 278 | 18,868 | 1,297,751 | 1.3 M to 1.3 M (-0.02 %) |
| Apr 10 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 67.87 | 48 | 3,258 | 256,229 | 256.3 K to 256.2 K (-0.02 %) |
| Apr 10 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 67.87 | 28 | 1,900 | 165,834 | 165.9 K to 165.8 K (-0.02 %) |
| Apr 10 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 67.87 | 2 | 136 | 50,526 | 50.5 K to 50.5 K (0.00 %) |
| Apr 10 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 67.87 | 31 | 2,104 | 180,373 | 180.4 K to 180.4 K (-0.02 %) |
| Apr 10 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 67.90 | 18,661 | 1,267,017 | 8,182,908 | 8.2 M to 8.2 M (-0.23 %) |
| Apr 10 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 67.90 | 2,865 | 194,523 | 1,298,029 | 1.3 M to 1.3 M (-0.22 %) |
| Apr 10 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 67.90 | 494 | 33,541 | 256,277 | 256.8 K to 256.3 K (-0.19 %) |
| Apr 10 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 67.90 | 286 | 19,418 | 165,862 | 166.1 K to 165.9 K (-0.17 %) |
| Apr 10 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 67.90 | 22 | 1,494 | 50,528 | 50.6 K to 50.5 K (-0.04 %) |
| Apr 10 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 67.90 | 320 | 21,727 | 180,404 | 180.7 K to 180.4 K (-0.18 %) |
| Apr 05 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 68.72 | 42,863 | 2,945,370 | 8,201,569 | 8.2 M to 8.2 M (-0.52 %) |
| Apr 05 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 68.72 | 6,581 | 452,219 | 1,300,894 | 1.3 M to 1.3 M (-0.50 %) |
| Apr 05 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 68.72 | 1,134 | 77,924 | 256,771 | 257.9 K to 256.8 K (-0.44 %) |
| Apr 05 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 68.72 | 658 | 45,215 | 166,148 | 166.8 K to 166.1 K (-0.39 %) |
| Apr 05 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 68.72 | 50 | 3,436 | 50,550 | 50.6 K to 50.6 K (-0.10 %) |
| Apr 05 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 68.72 | 734 | 50,437 | 180,724 | 181.5 K to 180.7 K (-0.40 %) |
| Apr 05 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 68.63 | 21,116 | 1,449,147 | 8,244,432 | 8.3 M to 8.2 M (-0.26 %) |
| Apr 05 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 68.63 | 3,242 | 222,492 | 1,307,475 | 1.3 M to 1.3 M (-0.25 %) |
| Apr 05 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 68.63 | 559 | 38,363 | 257,905 | 258.5 K to 257.9 K (-0.22 %) |
| Apr 05 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 68.63 | 324 | 22,235 | 166,806 | 167.1 K to 166.8 K (-0.19 %) |
| Apr 05 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 68.63 | 25 | 1,716 | 50,600 | 50.6 K to 50.6 K (-0.05 %) |
| Apr 05 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 68.63 | 362 | 24,843 | 181,458 | 181.8 K to 181.5 K (-0.20 %) |
| Apr 05 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 66.64 | 66,784 | 4,450,459 | 8,265,548 | 8.3 M to 8.3 M (-0.80 %) |
| Apr 05 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 66.64 | 10,253 | 683,256 | 1,310,717 | 1.3 M to 1.3 M (-0.78 %) |
| Apr 05 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 66.64 | 1,768 | 117,819 | 258,464 | 260.2 K to 258.5 K (-0.68 %) |
| Apr 05 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 66.64 | 1,025 | 68,306 | 167,130 | 168.2 K to 167.1 K (-0.61 %) |
| Apr 05 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 66.64 | 78 | 5,198 | 50,625 | 50.7 K to 50.6 K (-0.15 %) |
| Apr 05 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 66.64 | 1,145 | 76,302 | 181,820 | 183 K to 181.8 K (-0.63 %) |
| Apr 05 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 68.90 | 80,146 | 5,521,963 | 8,332,332 | 8.4 M to 8.3 M (-0.95 %) |
| Apr 05 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 68.90 | 12,305 | 847,800 | 1,320,970 | 1.3 M to 1.3 M (-0.92 %) |
| Apr 05 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 68.90 | 2,121 | 146,134 | 260,232 | 262.4 K to 260.2 K (-0.81 %) |
| Apr 05 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 68.90 | 1,230 | 84,746 | 168,155 | 169.4 K to 168.2 K (-0.73 %) |
| Apr 05 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 68.90 | 93 | 6,408 | 50,703 | 50.8 K to 50.7 K (-0.18 %) |
| Apr 05 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 68.90 | 1,374 | 94,667 | 182,965 | 184.3 K to 183 K (-0.75 %) |
| Apr 03 2019 | IDRA | IDERA PHARMACEUTIC ... | BAKER BROS. ADVISORS LP | Director | Grant | A | 2.59 | 4,161 | 10,777 | 89,233 | 85.1 K to 89.2 K (+4.89 %) |
| Apr 03 2019 | IDRA | IDERA PHARMACEUTIC ... | BAKER BROS. ADVISORS LP | Director | Grant | A | 2.59 | 4,161 | 10,777 | 4,288,031 | 4.3 M to 4.3 M (+0.10 %) |
| Apr 03 2019 | IDRA | IDERA PHARMACEUTIC ... | BAKER BROS. ADVISORS LP | Director | Grant | A | 2.59 | 4,161 | 10,777 | 526,724 | 522.6 K to 526.7 K (+0.80 %) |
| Apr 03 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Grant | A | 66.84 | 298 | 19,918 | 8,412,478 | 8.4 M to 8.4 M (0.00 %) |
| Apr 03 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Grant | A | 66.84 | 298 | 19,918 | 1,333,275 | 1.3 M to 1.3 M (+0.02 %) |
| Apr 03 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Grant | A | 66.84 | 298 | 19,918 | 262,353 | 262.1 K to 262.4 K (+0.11 %) |
| Apr 03 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Grant | A | 66.84 | 298 | 19,918 | 169,385 | 169.1 K to 169.4 K (+0.18 %) |
| Apr 03 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Grant | A | 66.84 | 298 | 19,918 | 50,796 | 50.5 K to 50.8 K (+0.59 %) |
| Apr 03 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Grant | A | 66.84 | 298 | 19,918 | 184,339 | 184 K to 184.3 K (+0.16 %) |
| Apr 02 2019 | INCY | INCYTE CORP | BAKER BROS. ADVISORS LP | Director | Grant | A | 86.01 | 220 | 18,922 | 811,082 | 810.9 K to 811.1 K (+0.03 %) |
| Apr 02 2019 | INCY | INCYTE CORP | BAKER BROS. ADVISORS LP | Director | Grant | A | 86.01 | 220 | 18,922 | 29,289,013 | 29.3 M to 29.3 M (0.00 %) |
| Apr 02 2019 | INCY | INCYTE CORP | BAKER BROS. ADVISORS LP | Director | Grant | A | 86.01 | 220 | 18,922 | 4,428,484 | 4.4 M to 4.4 M (0.00 %) |
| Mar 25 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 74.71 | 46,678 | 3,487,122 | 8,412,180 | 8.5 M to 8.4 M (-0.55 %) |
| Mar 25 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 74.71 | 7,167 | 535,417 | 1,332,977 | 1.3 M to 1.3 M (-0.53 %) |
| Mar 25 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 74.71 | 1,235 | 92,262 | 262,055 | 263.3 K to 262.1 K (-0.47 %) |
| Mar 25 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 74.71 | 716 | 53,489 | 169,087 | 169.8 K to 169.1 K (-0.42 %) |
| Mar 25 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 74.71 | 55 | 4,109 | 50,498 | 50.6 K to 50.5 K (-0.11 %) |
| Mar 25 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 74.71 | 800 | 59,765 | 184,041 | 184.8 K to 184 K (-0.43 %) |
| Mar 19 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 74.34 | 41,281 | 3,068,962 | 8,458,858 | 8.5 M to 8.5 M (-0.49 %) |
| Mar 19 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 74.34 | 6,338 | 471,187 | 1,340,144 | 1.3 M to 1.3 M (-0.47 %) |
| Mar 19 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 74.34 | 1,092 | 81,183 | 263,290 | 264.4 K to 263.3 K (-0.41 %) |
| Mar 19 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 74.34 | 634 | 47,134 | 169,803 | 170.4 K to 169.8 K (-0.37 %) |
| Mar 19 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 74.34 | 48 | 3,568 | 50,553 | 50.6 K to 50.6 K (-0.09 %) |
| Mar 19 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 74.34 | 707 | 52,561 | 184,841 | 185.5 K to 184.8 K (-0.38 %) |
| Mar 19 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 74.34 | 41,281 | 3,068,962 | 8,458,858 | 8.5 M to 8.5 M (-0.49 %) |
| Mar 19 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 74.34 | 6,338 | 471,187 | 1,340,144 | 1.3 M to 1.3 M (-0.47 %) |
| Mar 19 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 74.34 | 1,092 | 81,183 | 263,290 | 264.4 K to 263.3 K (-0.41 %) |
| Mar 19 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 74.34 | 634 | 47,134 | 169,803 | 170.4 K to 169.8 K (-0.37 %) |
| Mar 19 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 74.34 | 48 | 3,568 | 50,553 | 50.6 K to 50.6 K (-0.09 %) |
| Mar 19 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 74.34 | 707 | 52,561 | 184,841 | 185.5 K to 184.8 K (-0.38 %) |
| Mar 19 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 74.63 | 86,620 | 6,464,529 | 8,500,139 | 8.6 M to 8.5 M (-1.01 %) |
| Mar 19 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 74.63 | 13,298 | 992,442 | 1,346,482 | 1.4 M to 1.3 M (-0.98 %) |
| Mar 19 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 74.63 | 2,293 | 171,129 | 264,382 | 266.7 K to 264.4 K (-0.86 %) |
| Mar 19 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 74.63 | 1,329 | 99,184 | 170,437 | 171.8 K to 170.4 K (-0.77 %) |
| Mar 19 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 74.63 | 101 | 7,538 | 50,601 | 50.7 K to 50.6 K (-0.20 %) |
| Mar 19 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 74.63 | 1,485 | 110,827 | 185,548 | 187 K to 185.5 K (-0.79 %) |
| Mar 19 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 74.19 | 90,251 | 6,695,487 | 8,586,759 | 8.7 M to 8.6 M (-1.04 %) |
| Mar 19 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 74.19 | 13,856 | 1,027,941 | 1,359,780 | 1.4 M to 1.4 M (-1.01 %) |
| Mar 19 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 74.19 | 2,388 | 177,160 | 266,675 | 269.1 K to 266.7 K (-0.89 %) |
| Mar 19 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 74.19 | 1,385 | 102,750 | 171,766 | 173.2 K to 171.8 K (-0.80 %) |
| Mar 19 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 74.19 | 106 | 7,864 | 50,702 | 50.8 K to 50.7 K (-0.21 %) |